Assessment of Motor Reserve in the Preclinical Stages of Dementia

Recruiting Observational Study
Mild Cognitive Impairment (MCI)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Istituto per la Ricerca e l'Innovazione Biomedica · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Mild Cognitive Impairment (MCI) is a clinical condition associated with an increased risk of progression to dementia. Although cognitive alterations have traditionally been the main focus of investigation, growing evidence suggests that motor changes may also emerge during the early stages of cognitive decline and may represent potential preclinical indicators of disease. In this context, the con…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with Mild Cognitive Impairment (MCI) group * Diagnosis of MCI according to the international criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA) (Albert et al., 2011; McKhann et al., 2011). * Age between 40 and 85 years. * Native Italia…
Contacts

Domenico co Bosco, Medical Doctor

0961/883021

nico.bosco@libero.it

CONTACT